Skip to content

Study · Not a test of the peptide alone · 2008

1 result

A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids.

Kongnyuy EJ, van den Broek N, Wiysonge CS

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics25 Sept 2007Cited by 39 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01HumanNot a test of Oxytocin aloneSystematic reviewEfficacy outcome

    In a systematic review of RCTs of myomectomy, enucleation by morcellation and oxytocin showed no evidence of an effect on blood loss.

    In plain wordsIn a review of trials of myomectomy, morcellation with oxytocin showed no evidence of less blood loss.

    Peptide
    Oxytocin
    Outcome
    No significant changeBlood loss during myomectomy
    Study

    n: not reported in source

    Outcome group
    Bleeding and clotting · Reproductive and sexual health

    Source sentences

    Summary
    There was no evidence of effect in blood loss with myoma enucleation by morcellation and oxytocin.
    1 context sentence
    Summary · context
    Electronic searches of the Cochrane Library, MEDLINE, and EMBASE, between 1966 and 2006 for randomized controlled trials (RCTs).

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.